Aggrenox
These highlights do not include all the information needed to use AGGRENOX safely and effectively. See full prescribing information for AGGRENOX. AGGRENOX® (aspirin/extended-release dipyridamole) CapsulesInitial U.S. Approval: 1999
Approved
Approval ID
f07c8535-f9fb-4697-9b63-1ab22210efc9
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Aug 6, 2016
Manufacturers
FDA
Carilion Materials Management
DUNS: 079239644
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
aspirin and dipyridamole
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code68151-3971
Application NumberNDA020884
Product Classification
M
Marketing Category
C73594
G
Generic Name
aspirin and dipyridamole
Product Specifications
Route of AdministrationORAL
Effective DateJuly 26, 2016
FDA Product Classification
INGREDIENTS (2)
DIPYRIDAMOLEActive
Quantity: 200 mg in 1 1
Code: 64ALC7F90C
Classification: ACTIB
ASPIRINActive
Quantity: 25 mg in 1 1
Code: R16CO5Y76E
Classification: ACTIB